Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53 M Kappler, M Bache, F Bartel, M Kotzsch, M Panian, P Würl, K Blümke, ... Cancer gene therapy 11 (3), 186-193, 2004 | 212 | 2004 |
Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma H Taubert, T Greither, D Kaushal, P Würl, M Bache, F Bartel, A Kehlen, ... Oncogene 26 (7), 1098-1100, 2007 | 181 | 2007 |
Multiparametric immune profiling in HPV–oral squamous cell cancer Z Feng, D Bethmann, M Kappler, C Ballesteros-Merino, A Eckert, RB Bell, ... JCI insight 2 (14), 2017 | 157 | 2017 |
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. S Ning, S Fuessel, M Kotzsch, K Kraemer, M Kappler, U Schmidt, ... International journal of oncology 25 (4), 1065-1136, 2004 | 133 | 2004 |
Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients M Kappler, T Köhler, C Kampf, P Diestelkötter, P Würl, M Schmitz, F Bartel, ... International journal of cancer 95 (6), 360-363, 2001 | 127 | 2001 |
HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression J Kessler, A Hahnel, H Wichmann, S Rot, M Kappler, M Bache, ... BMC cancer 10, 1-11, 2010 | 126 | 2010 |
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival M Kappler, M Kotzsch, F Bartel, S Füssel, C Lautenschläger, ... Clinical cancer research 9 (3), 1098-1104, 2003 | 124 | 2003 |
Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies M Bache, M Kappler, HM Said, A Staab, D Vordermark Current medicinal chemistry 15 (4), 322-338, 2008 | 123 | 2008 |
Significance of HDMX‐S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis F Bartel, J Schulz, A Böhnke, K Blümke, M Kappler, M Bache, H Schmidt, ... International journal of cancer 117 (3), 469-475, 2005 | 121 | 2005 |
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma P Würl, M Kappler, A Meye, F Bartel, T Köhler, C Lautenschläger, ... The Lancet 359 (9310), 943-945, 2002 | 114 | 2002 |
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma AW Eckert, C Wickenhauser, PC Salins, M Kappler, J Bukur, B Seliger Journal of translational medicine 14, 1-13, 2016 | 111 | 2016 |
The role of survivin for radiation therapy G Capalbo, RH Stauber, SK Knauer, M Bache, M Kappler Strahlentherapie und Onkologie 183 (11), 593-599, 2007 | 109 | 2007 |
Amplification of the mdm2 gene, but not expression of splice variants of mdm2 mrna, is associated with prognosis in soft tissue sarcoma F Bartel, A Meye, P Würl, M Kappler, M Bache, C Lautenschläger, ... International journal of cancer 95 (3), 168-175, 2001 | 103 | 2001 |
Prognostic impact of HIF-1 [alpha] expression in patients with definitive radiotherapy for cervical cancer K Dellas, M Bache, SU Pigorsch, H Taubert, M Kappler, D Holzapfel, ... Strahlentherapie und Onkologie 184 (3), 169, 2008 | 90 | 2008 |
Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients AW Eckert, M Kappler, J Schubert, H Taubert Oral and maxillofacial surgery 16, 189-196, 2012 | 86 | 2012 |
Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not … M Kappler, H Taubert, F Bartel, K BLümke, M Panian, H Schmidt, J Dunst, ... Oncology reports 13 (1), 167-172, 2005 | 86 | 2005 |
Co‐expression of Hif1α and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients AW Eckert, MHW Lautner, A Schütze, K Bolte, M Bache, M Kappler, ... Journal of oral pathology & medicine 39 (4), 313-317, 2010 | 77 | 2010 |
Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients H Taubert, P Würl, T Greither, M Kappler, M Bache, F Bartel, A Kehlen, ... Oncogene 26 (50), 7170-7174, 2007 | 68 | 2007 |
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients H Taubert, M Kappler, M Bache, F Bartel, T Köhler, C Lautenschläger, ... Oncogene 24 (33), 5258-5261, 2005 | 68 | 2005 |
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft‐tissue sarcoma patients T Greither, P Würl, L Grochola, G Bond, M Bache, M Kappler, ... International Journal of Cancer 130 (5), 1230-1235, 2012 | 61 | 2012 |